Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 15.06.2026 1 BMC Neurol 2 Brain 5 J Neurol 4 Mult Scler 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. AHMED AM, Mistry N, Gehad AS, Hassan AM, et al
   Inflammatory CADASIL: the cross-link between CADASIL and multiple sclerosis: a report of two cases and systematic review of the literature.
   BMC Neurol. 2026;26:373.
   PubMed         Abstract available
   
   

   
   Brain

2. TUR C, Susin-Calle S, Otero-Romero S, Carvajal R, et al
   Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
   Brain. 2026 Jun 10:awag047. doi: 10.1093.
   PubMed         Abstract available
   
   
3. ARNABOLDI PM, Becker J, Nath A, Coyle PK, et al
   Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.
   Brain. 2026 May 18:awag016. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Neurol

4. GUGER M, Enzinger C, Heschl B, Di Pauli F, et al
   The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.
   J Neurol. 2026;273:392.
   PubMed         Abstract available
   
   
5. FOTTINGER F, Krajnc N, Berek K, Nolte JP, et al
   Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.
   J Neurol. 2026;273:382.
   PubMed         Abstract available
   
   
6. ESPOSITO F, Misra K, Doyle F, Clarelli F, et al
   Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.
   J Neurol. 2026;273:374.
   PubMed         Abstract available
   
   
7. REUTER E, Luerweg J, Katsimpoura M, Haselon J, et al
   Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.
   J Neurol. 2026;273:372.
   PubMed         Abstract available
   
   
8. HOF SN, Keytsman E, Fuchs TAN, Wessels MHJ, et al
   What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
   J Neurol. 2026;273:355.
   PubMed         Abstract available
   
   

   
   Mult Scler

9. CHEN H, Cortese M, Flores-Torres MH, Chen X, et al
   Comorbidities and lifestyle changes as predictors of the multiple sclerosis prodrome: A prospective cohort study.
   Mult Scler. 2026 Jun 10:13524585261454827. doi: 10.1177/13524585261454827.
   PubMed         Abstract available
   
   
10. HAMEDANI M, Lombardi G, Boffa G, Pistarini C, et al
    Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.
    Mult Scler. 2026 Jun 9:13524585261450820. doi: 10.1177/13524585261450820.
    PubMed         Abstract available
    
    
11. MCCURDY S, Sheng E, Jalaleddini K, Datta G, et al
    Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.
    Mult Scler. 2026;32:711-721.
    PubMed         Abstract available
    
    
12. TALLANTYRE EC, Apap Mangion S, Teunissen CE
    A framework for blood biomarker discovery in MS.
    Mult Scler. 2026;32:661-669.
    PubMed         Abstract available
    
    

    
    Neurology

13. GUINEBRETIERE O, Yang F, Wei D, Calonge Q, et al
    Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).
    Neurology. 2026;107:e218072.
    PubMed         Abstract available
    
    

    
    PLoS One

14. GIOVANNETTI AM, Giordano A, Donarelli E, Di Domenico G, et al
    Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development.
    PLoS One. 2026;21:e0349034.
    PubMed         Abstract available
    
    
15. MARIKI A, Kohlmeier KA, Mousavi SM, Keyhani A, et al
    Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone -induced multiple sclerosis model.
    PLoS One. 2026;21:e0349675.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum